February 22, 2013 | 6:48 AM | By

J&J Study Predicted 37% Failure Rate for Hip Implants

Michael Kelly, attorney for plaintiff Loren Kransky, holds up an ASR XL hip implant made by Johnson & Johnson during his opening statement to the jury at the trial of Kransky v. DePuy, at California Superior Court in Los Angeles, on Friday, Jan. 25, 2013. (Credit: Patrick T. Fallon/Bloomberg)

Michael Kelly, attorney for plaintiff Loren Kransky, holds up an ASR XL hip implant in his opening statement to the jury during the trial of Kransky v. DePuy, at the California Superior Court house in Los Angeles, California, U.S., on on Friday, January 25, 2013. The plaintiff’s attorney, representing Loren Kransky, a retired prison guard who got an ASR XL hip implant in 2007, said Johnson & Johnson failed to warn of the risks of defective metal hip implants it pulled from the market. J&J faced 10,100 lawsuits through September, according to a regulatory filing. Photographer: Patrick Fallon/Bloomberg

About the author

Rachael Myrow hosts the California Report for KQED. Over 14 years in public radio, she's specialized in covering heavy, complicated stuff like economics, transportation and politics. But every now and then, she does manage to squeeze in a feature about fruit, booze, sushi, and other consumer issues related to food and drink. View all posts by Rachael Myrow →